Favicon
Favicon

Todd Allen

Date: September 17, 2024 By:

We are deeply saddened to announce the passing of Ragon Institute faculty member Todd M. Allen, PhD, a pioneering researcher in T cell immunotherapy and HIV evolution and transmission. His groundbreaking work on HIV cure research has left an indelible mark on the field and has been an inspiration to many. In addition to his position at the Ragon, he was also a Professor of Medicine at Harvard Medical School as well as an Associate Member of the Broad Institute of MIT and Harvard.

Dr. Allen was not just a valued scientist and colleague. He was a cornerstone of the Ragon community, having been with us since 2001 and having helped to guide the establishment of the Institute. Beyond his professional achievements that brought him international recognition, Dr. Allen was known for his warmth and generosity as a colleague, friend, husband, and father. 

Dr. Allen’s presence at the Ragon Institute will be profoundly missed, and our thoughts are with his family and friends during this difficult time.

A memorial service will be held at 1 PM on Tuesday, September 17, at the Ragon Institute, 600 Main Street, Cambridge, MA 02139. A remote link is available here for those who cannot attend in person: https://partners.zoom.us/j/82353566586

More News

Press Releases

Ringel Lab Study Reveals Age-Related Decline in Tumor-Fighting T Cells and Its Impact on Cancer Treatment

Researchers at the Ragon Institute of Mass General Brigham, MIT, and Harvard have uncovered critical insights into how aging impairs the immune system’s ability to fight cancer.

Press Releases

New Research from the Ragon and Broad Unveils the Protective Role of CD4+ T Cells in Tuberculosis Reinfection

This study, published in Immunity on August 30, used a non-human primate model to demonstrate that previous Mtb infection leads to a durable, protective immune response that is dependent on CD4+ T cells.

Press Releases

MIT News – A two-dose schedule could make HIV vaccines more effective

MIT researchers find that the first dose primes the immune system, helping it to generate a strong response to the second dose, a week later.